A randomised trial to compare ASPIRIN versus HYDROXYUREA/ASPIRIN in 'intermediate risk' primary thrombocythaemia and ASPIRIN only with observation in 'Low risk' primary thrombocythaemia

Mise à jour : Il y a 5 ans
Référence : EUCTR2004-000245-38

Femme et Homme

  • | Pays :
  • -
  • | Organes :
  • -
  • | Spécialités :
  • -

Extrait

1) In low risk patients (aged > or = 18 years and < 40 years) : What is the incidence of thrombosis and major haemorrhage while receiving aspirin only? 2) In intermediate risk patients (aged 40-59 years) : Does hydroxyurea reduce thrombosis and major haemorrhage when added to aspirin? 3) What is the effect of the treatment modalities on quality of life?


Critère d'inclusion

  • Intermediate risk and low risk primary thrombocythaemia

Liens